Risk-reducing salpingo-oophorectomy (RRSO) reduces the relative risk of ovarian cancer by about 80% [2] and breast cancer by about 40% in woman with BRCA1/2 mutations who had no history of breast cancer [3]. This evidence concerns the gene BRCA1 and ovarian carcinoma.